Theratechnologies Incorporated

Theratechnologies is a Canadian biopharmaceutical company engaged in the field of therapeutic peptides targeting endocrine and metabolic disorders. Through its subsidiary, Celmed BioSciences, the Company is also active in the field of cell therapy using adult stem cells.

Contact Details: 630 Rene-Levesque Boulevard West 5th Floor Montreal Quebec H3B 1S6 Canada Tel: 514 877 0077 Fax: 514 877 3177 Email: webinfo@theratech.com WWW: www.thrt.com/

Loading...

Recent Publications by Theratechnologies Incorporated:
Sequential design approaches for bioequivalence studies with crossover designs. The planning of bioequivalence (BE) studies, as for any clinical trial,...	16th June, 2009	Theratechnologies Inc., Montreal, Quebec, Canada.	Pharm Stat. 2008 Oct-Dec;7(4):245-62. DOI Direct Link
Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. TH9507, an analogue of human growth hormone-releasing factor (hGRF1-44NH2)...	16th March, 2007	Theratechnologies Inc., 2310 Boulevard Alfred Nobel, Montreal, QC, Canada.	Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):49-58. DOI Direct Link

BioNews Results for Theratechnologies Incorporated:
Theratechnologies presents results at European AIDS Conference	Pharma Live:  Nov 13 2009 12:22AM Matching: theratechnologies
Theratechnologies Presents Combined Phase 3 Clinical Results at European AIDS Conference	Genetic Engineering News:  Nov 12 2009 12:30PM Matching: theratechnologies
Theratechnologies Presents Combined Phase 3 Clinical Results At European AIDS Conference	Medical News Today:  Nov 12 2009 6:34PM Matching: theratechnologies
Theratechnologies' NDA for Tesamorelin to be Reviewed by an FDA Advisory Committee	Individual.com:  Nov 5 2009 11:57PM Matching: theratechnologies
Theratechnologies' NDA for Tesamorelin to be Reviewed by an FDA Advisory Committee	Individual.com:  Nov 5 2009 11:57PM Matching: theratechnologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Theratechnologies Incorporated news.

Theratechnologies Incorporated Clinical Trials:
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Theratechnologies Incorporated Patents:
US Patent No.	Title
7538185	Glucagon-like peptide-1 analogs with long duration of action
5798523	Irradiating apparatus using a scanning light source for photodynamic treatment
5817627	Long-acting galenical formulation for GRF peptides
5834418	Process for the preparation of platelet growth factors extract
5837204	System for disinfecting the water lines of a dental unit
→View more Theratechnologies Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 411 times since April 2007, the link to the organisation's website has been followed 88 times

Search for more companies in Montreal

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Theratechnologies Incorporated